Changes of serum and extracellular ion concentrations occur regularly in patients with chronic kidney disease (CKD). Recently, hypocalcemia, i.e. a decrease of the extracellular calcium concentration [Ca 2+ ]o, has been suggested as potential pathomechanism contributing to the unexplained high rate of sudden cardiac death (SCD) in CKD patients. In particular, there is a hypothesis that hypocalcaemia could slow down natural pacemaking in the human sinus node to fatal degrees. Here, we address the question whether there are inter-species differences in the response of cellular sinus node pacemaking to changes of [Ca 2+ ]o. Towards this end, we employ computational models of mouse, rabbit and human sinus node cells. The Fabbri et al. human model was updated to consider changes of intracellular ion concentrations. We identified crucial inter-species differences in the response of cellular pacemaking in the sinus node to changes of [Ca 2+ ]o with little changes of cycle length in mouse and rabbit models (<83 ms) in contrast to a pronounced bradycardic effect in the human model (up to >1000 ms). Our results suggest that experiments with human sinus node cells are required to investigate the potential mechanism of hypocalcaemia-induced bradycardic SCD in CKD patients and small animal models are not well suited.
I. INTRODUCTION
The extracellular milieu in mammals is tightly controlled, i.e. amongst others the concentration of the essential electrophysiological ions is kept almost constant under physiological conditions. In disease conditions such as chronic kidney disease (CKD), the body can fail to regulate the ion concentrations including [K + ] o and [Ca 2+ ] o . Patients suffering from CKD have an exceptionally high risk of sudden cardiac death (SCD). Indeed, it is 14x higher than in cardiovascular patients with normal kidney function [1] . This high rate in CKD patients cannot be explained by traditional SCD risk factors and recent clinical studies using implantable loop recorders point towards severe bradycardia and asystole as the prevailing arrhythmias causing SCD in CKD patients [2] , [3] . An initial computational study from our group suggests a slowing of the cellular pacemaking rate in the human sinus node caused by reduced [Ca 2+ ] o
We gratefully acknowledge financial support by the Deutsche Forschungsgemeinschaft (DFG) through CRC 1173. and by the National Research Development and Innovation Office (NKFIH PD-125402 and FK-129117). 1 as a likely mechanism causing bradycardic SCD in CKD patients [4] . In vitro confirmation of this in silico finding is required. However, it is not clear which experimental setting (i.e. human vs. animal sinus node cells) is suitable considering the marked difference in pacemaking rate (mouse: 500bpm, rabbit: 300bpm, dog: 100bpm; human: 60bpm). Therefore, we study inter-species differences of sinus node cellular pacemaking response to [Ca 2+ ] o changes using computational models of rabbit, mouse, and human sinus node cells together with rabbit experimental data.
II. METHODS

A. Model Extension
The original Fabbri et al. model [5] considers constant intracellular K + and N a + concentrations, which is a valid assumption during cyclic steady-state simulations at the reference extracellular concentrations. However, the intracellular concentrations are likely to respond to changes of the extracellular concentrations. Therefore, we extended the model to account for the dynamic intracellular K + and N a + balance based on the influx and efflux of ions carrying the transmembrane currents. Moreover, we included a current through the small conductance calcium-activated potassium channel (I SK ) as proposed before [6] , [7] . Lastly, we considered the dependance of the maximal I Kr conductance g Kr on [K + ] o as described before for other cardiomyocytes [8] :
(1) After introducing the changes to the model equations, the parameters in the upper part of Table I were optimized with respect to a cost function considering the experimental values in Table II and the existence of a cyclic steadystate similar to the method used for the original Fabbri et al. model detailed in [5] . Table I lists the optimized  parameter values, Table III gives the initial values. The updated model was validated against experimental action potential (AP) and calcium transient (CaT) recordings as well as the effect of mutations similarly to the validation of the original model [5] .
B. Inter-Species Comparison
To compare the effect of [Ca 2+ ] o changes on sinus node cellular pacemaking between species, we used the Garny et al. [9] and Severi et al. [10] rabbit models as well as the Kharche et al. mouse model [11] besides the original and updated human models described above. In all of the models, [Ca 2+ ] o was varied between 0.9 and 2.9 mM. The coupled systems of ordinary differential equations were numerically integrated for 100 s to reach a cyclic steady-state. As wetlab data on this phenomenon are very sparse, we performed experiments in isolated sinus node tissue from young New-Zealand white rabbits at 37 • C to complement our computational analyses. The protocol was approved by the Review Board of the Department of Animal Health and Food Control of the Ministry of Agriculture and Rural Development, Hungary (XIII./1211/2012). The details of the conventional microelectrode technique were described before [12] . The calcium content of the bath solution was varied (0.9 / 1.35 / 1.8 mM) and the cycle length of spontaneous beating rate was determined from AP recordings in n=6 rabbits. Abbreviations: maximum diastolic potential (MDP); AP duration (APD), diastolic depolarization rate over the first 100 ms of diastolic depolarization (DDR 100 ); CaT duration (CaTD). [13] . AP features of the updated model were closer to experimental values than those of the original model except for APD 90 , AP overshoot, and the diastolic depolarization rate during the first 100 ms (DDR 100 ) which is higher in the updated model leading to a more pronounced biphasic diastolic deploarization. The CaT was of higher amplitude and shorter duration at 20% and 50% repolarization but longer duration at 90% repolarization. The effect of I f , I N a , and I Ks mutations (Fig. 1) was not markedly affected by the changes to the model with a tendency towards bigger effects for HCN4 mutations and smaller effects for SCN5A mutations. The response to complete I f block (cycle length +25.9%) was in accordance with the available experimental human data (+26% [13] ). Fig. 2A shows how the different models respond to changes of [Ca 2+ ] o . While there is a consistent trend towards longer cycle length, i.e. bradycardia, under hypocalcaemic conditions, it is intriguingly stronger in the human sinus node cell models ( Fig. 2A, Fig. 3A model, which is insensitive (Fig. 2B) (Fig. 2D,  Fig. 3C ). We dissected the contribution of the different phases of the pacemaking cycle to the cylce length dependence on [Ca 2+ ] o (Fig. 3A) . The effect of early depolarization is quantified by calculating a first order approximation of diastolic depolarization duration based on DDR 100 and a takeoff potential of -40 mV:
III. RESULTS
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t dia,late (Fig. 3D ) on the other hand quantifies all changes that are captured by neither changes in early depolarization (t dia,100 , Fig. 3B ) nor by changes in AP D 90 (Fig. 3C) 
IV. DISCUSSION
In this paper, we identified crucial inter-species differences in the response of cellular pacemaking in the sinus node to changes of extracellular ion concentrations, as commonly occurring in CKD patients. The bradycardic effect of hypocalcaemia was markedly more pronounced in the human models compared to small animal models. The [14] . Future studies could investigate the contribution of distinct currents and their complex interplay. Moreover, the analysis of autonomic regulation as well as pace-and-drive capability [15] adds other dimensions to the problem of bradycardic SCD. We conclude that the relevance of mouse and rabbit experiments to investigate the effect of electrolyte-induced changes of pacemaking appears questionable and human experiments are needed to investigate the potential mechanism of hypocalcaemia-induced bradycardic SCD in CKD patients. 
